Skip to main content

Company News

  • December 18, 2023

    CATTI and bioMérieux Canada are joining forces to support the development of a qualified workforce in advanced therapies

    CATTI, Canadian Advanced Therapies Training Institute, and bioMérieux Canada are combining their respective strengths to enhance the training of the workforce in advanced therapies and the production of quality control solutions (for the pharmaceutical industries).
    Read more

  • December 13, 2023

    bioMérieux celebrates the First Graduating Class of its Academy of microbiology in Latin America

    In 2020, bioMérieux launched an innovative educational program in Latin America dedicated to healthcare professionals to strenghten their understanding and practice of microbiology.
    Read more

  • November 28, 2023

    A Stronger Business Relationship to Enhance bioMérieux’s BIOFIRE® SPOTFIRE® Presence in the US Outpatient Diagnostic Market

    bioMérieux has strengthened its relationship with McKesson Medical-Surgical, a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere.
    Read more

  • April 20, 2023

    bioMérieux and JMI Labs partner against antimicrobial resistance (AMR)

    bioMérieux and JMI Laboratories (JMI) are announcing a six-year partnership to undertake collaborative projects evaluating the performance and increasing potential of rapid and innovative microbiology diagnostics as important tools in the battle against AMR.
    Read more

  • March 08, 2023

    March 8 – and every day –, let’s #EmbraceEquity

    At bioMérieux, we support the inclusion, well-being and development of our team members and are committed to creating a culture of belonging and acceptance where all feel respected, supported and included.
    Read more